In addition, a four-stratum risk-assessment tool has been proposed based on refined cut-off levels for WHO-FC, 6MWD, and NT-proBNP, categorizing patients with pulmonary hypertension as low, intermediate–low, intermediate–high, or high risk [22]. Here, NPPB is linked to pulmonary arterial hypertension.